Julie Gralow, Chief Medical Officer (CMO) of the American Society of Clinical Oncology, shared a post on X:
“The SWOG Pragmatica-Lung study is a model for pragmatic, efficient, patient-centered trial design.”
Read “SWOG S2302 Pragmatica-Lung Study Design Still Significant Even With Negative Results in Advanced NSCLC”.
More posts featuring Julie Gralow on OncoDaily.